301033 迈普医学
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.38511.8096.6016.1109.846
总资产报酬率 ROA (%)2.9929.9435.3374.8127.485
投入资产回报率 ROIC (%)3.37511.3355.9445.2438.356

边际利润分析
销售毛利率 (%)80.52279.32782.00684.00682.386
营业利润率 (%)38.71632.94120.90721.17628.425
息税前利润/营业总收入 (%)37.11832.98121.03120.41633.997
净利润/营业总收入 (%)32.78328.32017.70618.30229.055

收益指标分析
经营活动净收益/利润总额(%)89.08281.43785.95364.80251.317
价值变动净收益/利润总额(%)2.0973.8437.68419.98213.714
营业外收支净额/利润总额(%)-0.7741.540-0.511-3.46515.283

偿债能力分析
流动比率 (X)8.0306.5803.9592.9147.699
速动比率 (X)7.0685.8583.5752.5547.308
资产负债率 (%)10.78712.45819.20219.10822.887
带息债务/全部投入资本 (%)-6.625-7.1342.50510.63214.062
股东权益/带息债务 (%)-1,504.955-1,397.6803,680.851826.510595.461
股东权益/负债合计 (%)827.075702.717420.789423.348334.818
利息保障倍数 (X)-28.550-69.37291.336-398.06876.614

营运能力分析
应收账款周转天数 (天)29.28727.30622.21614.50715.292
存货周转天数 (天)220.412189.112240.943291.585250.574